Spruce Biosciences, Inc. (SPRB)
39.65
-1.82
(-4.39%)
USD |
NASDAQ |
Oct 16, 16:00
40.00
+0.35
(+0.88%)
After-Hours: 20:00
Spruce Biosciences Net Income (Quarterly) : -16.23M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.23M |
| March 31, 2026 | -12.27M |
| December 31, 2025 | -14.65M |
| September 30, 2025 | -8.212M |
| June 30, 2025 | -2.067M |
| March 31, 2025 | -14.04M |
| December 31, 2024 | -23.56M |
| September 30, 2024 | -8.671M |
| June 30, 2024 | -9.181M |
| March 31, 2024 | -11.62M |
| December 31, 2023 | -9.95M |
| September 30, 2023 | -12.35M |
| June 30, 2023 | -12.82M |
| March 31, 2023 | -12.79M |
| Date | Value |
|---|---|
| December 31, 2022 | -11.14M |
| September 30, 2022 | -11.40M |
| June 30, 2022 | -11.87M |
| March 31, 2022 | -11.76M |
| December 31, 2021 | -9.184M |
| September 30, 2021 | -11.45M |
| June 30, 2021 | -11.77M |
| March 31, 2021 | -9.887M |
| December 31, 2020 | -8.338M |
| September 30, 2020 | -9.587M |
| June 30, 2020 | -6.446M |
| March 31, 2020 | -5.168M |
| December 31, 2019 | -3.182M |
| September 30, 2019 | -2.551M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 16.23M |
| EPS Diluted (Quarterly) | -6.676 |
| Enterprise Value | 20.53M |
| Earnings Yield | -103.1% |
| Normalized Earnings Yield | -97.93 |